SIGLEC1 and neoplasm: Although the difference between SSMs from tumor-draining and non-draining lymph nodes was not as stark as in the case of FcgR1 and FcgR4, we measured increased co-localization of MMP14 and CCL4 with CD169+ SSMs in tumor-draining nodes (Supplementary Figure 3).